Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

304

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 144 sells.

Estimated insider holdings value: $173.5M based on current market prices.

Holdings by Company

UTHRJul 30, 2026

Current Shares333.9K

Value$173.32M

Net Activity-397,910

Bought: 0Sold: 397.9K

BETAJun 11, 2026

Current Shares8.2K

Value$182.3K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings (page 5)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 21, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,114	$348.03	$2,475,869.18	-22.2%	+2.6%	-11.6%
Aug 19, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	3,600	$344.18	$1,239,047.37	-8.6%	+3.0%	-10.1%
Aug 16, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$322.00	$2,318,396.95	-30.0%	+20.3%	-2.4%
Aug 14, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$326.17	$2,348,425.50	-22.5%	+23.8%	-3.6%
Aug 12, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,912	$332.74	$2,632,645.57	-43.1%	+20.0%	-9.7%
Aug 8, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$326.20	$2,348,641.20	-27.3%	+20.1%	-8.9%
Aug 6, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$323.55	$2,329,541.38	-23.7%	+17.0%	-6.1%
Aug 2, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,245	$324.44	$2,350,581.98	-15.6%	+14.1%	-10.2%
Jul 31, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	3,600	$318.39	$1,146,209.76	-17.8%	+12.6%	-12.3%
Jul 30, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$336.56	$2,423,235.38	-25.5%	+3.6%	-16.5%

← PrevPage 5Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC